Insight Molecular Diagnostics (IMDX) Acquisitions (2020 - 2021)

Insight Molecular Diagnostics' (IMDX) quarterly Acquisitions came in at $607000.0 in Q1 2021, down 90.19% year-on-year from $6.2 million in Q1 2020, and down 90.19% quarter-over-quarter from $6.2 million in Q1 2020.

Insight Molecular Diagnostics (IMDX) Acquisitions (2020 - 2021) Analysis & Trends

Insight Molecular Diagnostics has disclosed Acquisitions across 2 years of filings, most recently posting $607000.0 for Q1 2021.

  • Acquisitions for Q1 2021 came in at $607000.0, down 90.19% year-over-year; the trailing twelve-month figure through Dec 2021 was $607000.0 (down 90.19% YoY), and the FY2021 annual result was $607000.0, down 90.19% from the prior year.
  • Acquisitions came in at $607000.0 for Q1 2021 at Insight Molecular Diagnostics, down from $6.2 million in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $6.2 million in Q1 2020 to a low of $607000.0 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Waters 30,529.42 Bn 30,528.96 Bn 1.11 Bn 144.00 Mn
2 Thermo Fisher Scientific 183.75 Bn 180.50 Bn 7.74 Bn 8.87 Bn
3 Danaher 133.13 Bn 127.43 Bn 3.59 Bn -
4 Idexx Laboratories 46.14 Bn 45.94 Bn 722.74 Mn -
5 Agilent Technologies 38.20 Bn 36.39 Bn 990.00 Mn -
6 Natera 31.50 Bn 30.40 Bn 696.04 Mn -
7 Iqvia Holdings 31.34 Bn 29.36 Bn 1.36 Bn 37.00 Mn
8 Illumina 24.51 Bn 23.36 Bn 721.00 Mn 415.00 Mn
9 Mettler Toledo International 23.53 Bn 23.47 Bn 555.82 Mn 2.24 Mn
10 Insight Molecular Diagnostics 4.52 Mn -24.41 Mn 15,000.00 -

Historic Data

Download Data
DateValue
Mar 31, 2021 607,000.00
Mar 31, 2020 6.19 Mn